...
首页> 外文期刊>Surgery >Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.
【24h】

Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area.

机译:氟18-氟脱氧葡萄糖正电子发射断层显像在术前评估甲状腺肿的甲状腺结节。

获取原文
获取原文并翻译 | 示例
           

摘要

Background. The aim of this study was to evaluate the usefulness of fluorine-18-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) in the preoperative assessment of suspicious thyroid nodules. Methods. A total of 43 patients were examined before surgical resection. In all patients, imaging was obtained at 70 minutes after the intravenous administration of 180 MBq (18)F-FDG. Standard uptake values (SUVs) were calculated. Results. A total of 16 patients with thyroid carcinomas (11 papillary, 3 follicular, 2 anaplastic), 23 thyroid adenomas (11 microfollicular, 10 Hurthle cell, 2 macrofollicular), and 4 patients with degenerative goiter were found. (18)F-FDG uptake in Hurthle cell adenoma, thyroid cancer, microfollicular adenoma, degenerative goiter, and macrofollicular adenoma was 4.4 +/- 2.2, 3.7 +/- 1.9, 1.6 +/- 0.3, 1.2 +/- 0.2, and 0.9 +/- 0.1, respectively. Significant differences were observed between thyroid carcinomas and both microfollicular adenomas and degenerative goiters (P < 0.05), and between Hurthle cell adenomas and both microfollicular adenomas as well as degenerative goiter (P < 0.05). For diagnosis of thyroid carcinoma, 100% sensitivity, 63% specificity, and 100% negative predictive value was found when a cutoff value for SUV of 2 was used. Conclusions. Our results indicate that thyroid carcinomas, in contrast to most benign thyroid nodules, demonstrate significantly increased glucose metabolism. (18)F-FDG PET is unlikely to differentiate successfully all benign tumors from malignant tumors, but it can help select patients who need surgery, especially if cytology is inconclusive or malignancy cannot be excluded.
机译:背景。本研究的目的是评估氟18-氟脱氧葡萄糖正电子发射断层显像((18)F-FDG PET)在可疑甲状腺结节术前评估中的实用性。方法。手术切除前共检查了43例患者。在所有患者中,在静脉内注射180 MBq(18)F-FDG后70分钟均获得了成像。计算标准摄取值(SUV)。结果。共发现16例甲状腺癌患者(11例乳头状,3例滤泡性,2例间变性),23例甲状腺腺瘤(11例微泡,10个Hurthle细胞,2例大泡性甲状腺肿)和4例变性甲状腺肿。 (18)F-FDG在Hurthle细胞腺瘤,甲状腺癌,微泡腺瘤,变性甲状腺肿和大泡腺瘤中的摄取为4.4 +/- 2.2、3.7 +/- 1.9、1.6 +/- 0.3、1.2 +/- 0.2和分别为0.9 +/- 0.1。甲状腺癌与微囊腺瘤和变性甲状腺肿之间存在显着差异(P <0.05),Hurthle细胞腺瘤与微囊腺瘤和变性甲状腺肿之间存在显着差异(P <0.05)。当使用SUV的临界值为2时,对于甲状腺癌的诊断,发现100%的敏感性,63%的特异性和100%的阴性预测值。结论我们的结果表明,与大多数良性甲状腺结节相比,甲状腺癌显示葡萄糖代谢显着增加。 (18)F-FDG PET不太可能成功地将所有良性肿瘤与恶性肿瘤区分开,但是它可以帮助选择需要手术的患者,尤其是在细胞学尚无定论或不能排除恶性肿瘤的情况下。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号